Cargando…
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Heterozygous de novo mutations in the neuronal protein Munc18‐1 cause syndromic neurological symptoms, including severe epilepsy, intellectual disability, developmental delay, ataxia, and tremor. No disease‐modifying therapy exists to treat these disorders, and while chemical chaperones have been sh...
Autores principales: | Abramov, Debra, Guiberson, Noah Guy Lewis, Daab, Andrew, Na, Yoonmi, Petsko, Gregory A, Sharma, Manu, Burré, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799358/ https://www.ncbi.nlm.nih.gov/pubmed/33332765 http://dx.doi.org/10.15252/emmm.202012354 |
Ejemplares similares
-
Mechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones
por: Guiberson, Noah Guy Lewis, et al.
Publicado: (2018) -
Beyond the SNARE: Munc18-1 chaperones α-synuclein
por: Deshpande, Mugdha, et al.
Publicado: (2016) -
A dynamic template complex mediates Munc18-chaperoned SNARE assembly
por: Yang, Jie, et al.
Publicado: (2022) -
Munc18 and Munc13 regulate early neurite outgrowth
por: Broeke, Jurjen H.P., et al.
Publicado: (2010) -
Q&A: What are pharmacological chaperones and why are they interesting?
por: Ringe, Dagmar, et al.
Publicado: (2009)